Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

google.co.in

Google Alert - tezepelumab

Get the latest updates from Google Alert - tezepelumab directly as they happen.

Follow now 108 followers

Latest posts

Last updated about 2 hours ago

Asthma-Therapie: Tezepelumab zeigt Zilienregeneration in Pilotstudie - ad-hoc-news.de

about 5 hours ago

Tezepelumab verbesserte in einer Paduaer Pilotstudie die Asthmakontrolle und Lebensqualität; zudem gingen...

Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study

1 day ago

Unifind is a portal where you can discover the expertise within a...

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction ...

1 day ago

Tezepelumab eliminated severe exacerbations and achieved complete OCS withdrawal in 100% of...

Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study

1 day ago

Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study...

Tezepelumab in real-world US patients with severe asthma across phenotypes and ... - PMC - NIH

2 days ago

The PASSAGE study of a diverse, real-world US population with SUA treated...

Improvement of Severe Volume Dependent Airway Closure With Tezepelumab: A Case Report

2 days ago

... tezepelumab in modifying early airway remodeling beyond symptom control. Keywords: asthma...

Successful switch to tezepelumab for severe asthma and chronic rhinosinusitis with nasal polyps

2 days ago

清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic ... - PMC

2 days ago

This study compared the efficacy of tezepelumab with other approved biologics and...

Novel Two-Prong Biologic Shows Promise in Asthma - MedPage Today

2 days ago

One such TSLP blocker is tezepelumab (Tezspire)opens in a new tab or...

Corona-Impfung: Auffrischung künftig nur für Risikogruppen - ad-hoc-news.de

2 days ago

... Tezepelumab gestrichen. Eine ähnliche Bereinigung erfolgte im Bereich der Diabetes-Therapeutika: Die...

Asma grave, la Pneumologia di Cittadella protagonista al congresso europeo di Barcellona

2 days ago

Uno studio condotto tra Cittadella e Padova analizza gli effetti del farmaco...

Prana reports prolonged Type 2 biomarker suppression with IL-4Rα/TSLP bispecific - AllSci

3 days ago

... (tezepelumab), which targets TSLP alone. No approved biologic currently blocks both...